Mechanistic investigation of resistant HNSCC cells to c-MET targeting identified compensatory kinase pathways such as PI3K/AKT and RAS that overcome c-MET blockade and may prevent clinical efficiency in future application. Here, MET is linked to head and neck squamous cell carcinoma.